Hematology TimesCAR T-cell trial placed on hold againNovember 25, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesEC grants drug orphan status for AML, sarcomaNovember 24, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsDecitabine elicits favorable response in high-risk AML/MDSNovember 23, 2016AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIdelalisib held unlikely to become frontline therapy for CLLNovember 23, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPh-like ALL is highly prevalent in adultsNovember 23, 2016ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC expands indication for arsenic trioxide in APLNovember 23, 2016Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyAcute-onset hypokalemic paralysis with arsenic trioxide therapy in patient with acute promyelocytic leukemiaNovember 22, 2016Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyOutcome of tumor lysis syndrome in pediatric patients with hematologic malignancies – a single-center experience from PakistanNovember 22, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPatient & Survivor Care
The Journal of Community and Supportive OncologyFourth approved indication for ofatumumab in chronic lymphocytic leukemiaNovember 22, 2016Leukemia, Myelodysplasia, Transplantation
Hematology TimesNovel CLL drugs could greatly increase costsNovember 22, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesALL subtype ‘highly prevalent’ in adultsNovember 22, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsTargeted therapies predicted to blow out costs for CLLNovember 21, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesLarge-scale tumor profiling deemed feasible, but challenges remainNovember 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesCompound could treat leukemia, other cancersNovember 17, 2016Leukemia, Myelodysplasia, Transplantation
Hematology TimesCompany withdraws application for eryaspase in ALLNovember 16, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
